Beth Wensley joined BeiGene in May of 2022. Prior to joining BeiGene, she worked in the synthetic biology field joining AI and drug discovery. Her other previous experience includes biotech and pharma in program and portfolio management leadership from research to commercialization at Aviron, MedImmune, and AstraZeneca.

Beth holds a master’s degree in business administration from Santa Clara University and a master’s degree in environmental science from the University of Washington. She also has a bachelor’s degree in biology from California Lutheran University.